Dosimetric approach to 131I ablation therapy for the differentiated thyroid cancer

被引:0
|
作者
Gortan, Fatma Arzu [1 ]
Yuksel, Alptug Ozer [1 ]
Gulaldi, Nedim Cuneyt Murat [1 ]
Coskun, Nazim [1 ]
Akca, Ceren Deniz Kapulu [1 ]
机构
[1] Ankara City Hosp, Dept Nucl Med, Turkish Minist Hlth, Univ Mh Bilkent Cd 1, TR-06800 Ankara, Turkey
关键词
Residual tissue ablation; -Thyroid cancer; Dosimetric therapy; RADIOIODINE THERAPY;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective:The aim of this study is to compare the activity amounts used in the standard activity approach with the activity amounts calculated with the dosimetric method for the ablation of post-operative differentiated thyroid cancer residual tissue. Subjects and Methods:Seventeen patients (mean age=47.5 +/- 8.4 years) were included in the study. Time-activity curves were created by measuring iodine-131 (I-131) uptake values of residual tissue at 4(th ), 24(th ) 48(th )nd 96(th )ours following oral administration of I. In adosimetric I-131 proach, activity amounts exposing 300Gy to residual tissue were calculated using medical internal radiation dose (MIRD) formulation. Results:Dosimetric calculation could not be made in 3 patients because there was not enough radioactive iodine uptake (RAIU) at the neck to calculate the radioactive iodine treatment (RAIT) dose. The lowest and highest activity amounts determined by dosimetric calculations were 259MBq and 10860MBq, respectively. Dose amounts for the proposed treatment were decreased in 8 and increased in 6 patients compared to the standard activity approach. Cumulative activity (CA) and total cumulative activity (TCA) levels were found to be high in 1 patient who could not achieve adequate ablation. Conclusion:We recommend the dosimetric approach for ablation of residual postoperative thyroid tissue to find patients with high levels of CA and TCA levels to consider higher activity doses compared to risk stratification assessment.
引用
收藏
页码:260 / 268
页数:9
相关论文
共 50 条
  • [1] Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
    Doi, SAR
    Woodhouse, NJY
    [J]. CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 765 - 773
  • [2] 131I imaging in the therapy of differentiated thyroid cancer
    Vija, L. -M.
    Toubert, M. -E.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 44 - 51
  • [3] Prediction of Ablation Using a Simplified Dosimetric Approach After 131I Administration for Differentiated Thyroid Carcinomas
    Bourgeois, P.
    Ameye, L.
    Paesmans, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S343 - S343
  • [4] Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer
    Klubo-Gwiezdzinska, Joanna
    Van Nostrand, Douglas
    Atkins, Frank
    Burman, Kenneth
    Jonklaas, Jacqueline
    Mete, Mihriye
    Wartofsky, Leonard
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (10): : 3217 - 3225
  • [5] Prescribed Activity of 131I Therapy in Differentiated Thyroid Cancer
    Van Nostrand, Douglas
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) : 697 - 699
  • [6] Influencing factors of the first 131I ablation therapy for children and adolescents differentiated thyroid cancer
    Lina, L.
    Tian, T.
    Bin, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S622 - S622
  • [7] Clinical pathway of metabolic therapy with 131I in differentiated thyroid cancer
    Saiz, I. Blanco
    Apinaniz, E. Anda
    Arribas, J. Pineda
    Moreno, F. Caudepon
    Iglesias, A. Fernandez
    Jimenez, M. Huarte
    Munoz, A. I. de Miguel
    Aristorena, M. I. Irigoyen
    Girones, E. Goni
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (03): : 178 - 187
  • [8] Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131I Ablation Therapy for Differentiated Thyroid Cancer
    Hasbek, Zekiye
    Turgut, Bulent
    Kilicli, Fatih
    Altuntas, Emine Elif
    Yucel, Birsen
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (06) : 2523 - 2527
  • [9] Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer
    Ceccarelli, C
    Battisti, P
    Gasperi, M
    Fantuzzi, E
    Pacini, F
    Gualdrini, G
    Pierantoni, MC
    Luciani, A
    Djokich, D
    Pinchera, A
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (10) : 1716 - 1721
  • [10] Prognostic value of serial 131I scans in patinets with differentiated thyroid cancer after 131I therapy.
    Lu, HK
    Zhu, RS
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 410P - 410P